Tech Company Financing Transactions
GenomeDx Biosciences Funding Round
GenomeDx Biosciences closed a Series A funding round on 1/10/2012. Investors included Aeris Capital AG, Baird Capital and private investors.
Transaction Overview
Company Name
Announced On
1/10/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Aeris Capital AG (Lead Investor) (George Rehm)
Baird Capital (Lead Investor) (Michael Liang)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1152 Mainland St. 430
Vancouver BC, V6B 4X2
Canada
Vancouver BC, V6B 4X2
Canada
Phone
Website
Email Address
Overview
GenomeDx is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Douglas Dolginow
President
Elai Davicioni
VP - General Counsel
Adam Chinnock
Browse more venture capital transactions:
Prev: 1/10/2012: VideoIQ venture capital transaction
Next: 1/10/2012: EveryMove venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs